SCHEMBL21159595

SCHEMBL21159595

Nc1c(Cl)ncnc1N(N)Cc1ccc(F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.38
GALR3 O60755 1/20 0.35
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
PTPN1 P18031 1/20 0.34
SLC2A1 P11166 1/20 0.33
CSF1R P07333 1/20 0.33
TP53 P04637 1/20 0.33
AOC3 Q16853 1/20 0.33
KDM4C Q9H3R0 1/20 0.32
LMNA P02545 2/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 2/20 0.32
LOXL2 Q9Y4K0 1/20 0.32
MAPT P10636 1/20 0.31
MAOB P27338 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21159436 0.85 HTT (0.37) ESR1ESR2SLC2A1CSF1RTP53
SCHEMBL5248227 0.73 EGFR (0.38) CSF1RTP53LMNAALDH1A1SMN1; SMN2
SCHEMBL10873653 0.69 KDM4C (0.60) RAB9AGALR3TP53KDM4CLMNA
SCHEMBL21544332 0.69 ALDH1A1 (0.52) RAB9AGALR3CSF1RTP53LMNA
SCHEMBL21159607 0.67 ALDH1A1 (0.47) RAB9AGALR3AOC3LMNAALDH1A1
SCHEMBL21159461 0.67 HTT (0.37) RAB9AGALR3KDM4CLMNASMN1; SMN2
SCHEMBL17802579 0.67 RAB9A (0.75) RAB9AGALR3KDM4CLMNASMN1; SMN2
SCHEMBL934572 0.66 BCL2A1 (0.51) RAB9AESR1ESR2PTPN1AOC3
SCHEMBL933733 0.66 ESR1 (0.57) ESR1ESR2AOC3ALDH1A1LOXL2
Hydrochloric Acid SCHEMBL9457770 0.65 BCL2A1 (0.50) RAB9AESR1ESR2PTPN1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3505171-A1 BICYCLIC NITROGENATED HETEROCYCLIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2019-07-03 EP disclosed